Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin A palmitate eye gel for corneal protection during general anesthesia
ChiCTR2100052140Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of retinyl palmitate in corneal abrasion, Exposure keratitis (EK), dry eye syndrome (DED) and 1 more (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Corneal fluorescein staining. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
retinyl palmitate
03
Conditions
corneal abrasionExposure keratitis (EK)dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2100052140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052140.